Avant Technologies Inc. (OTCQB:AVAI), through its joint venture with Ainnova Tech, is advancing Vision AI—a clinical screening platform now on the FDA’s radar and already in deployment across Latin America and Asia. Issued on behalf of Avant Technologies Inc. Imagine a world where diseases are flagged before symptoms even appear. Where AI reads medical images … Continue reading Vision, Velocity, and Validation: The AI Platform Moving Toward FDA and Global Scale